Investigator Initiated Study - Asenapine Early Psychosis
NCT01968161
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia and Disorders With Psychotic Features
Disorders
Interventions
DRUG:
Asenapine
Sponsor
Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec